DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

References

Cohen H, Hunt BJ, Efthymiou M. , et al; RAPS trial investigators.
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial.

Lancet Haematol 2016;
3 (09) e426-e436

Download Bibliographical Data

Access: